IP Library Granted Patent US 8,575,344
Granted Patent B2
US 8,575,344 · App. 13/577,055 · Granted Nov 5, 2013

Process for preparing voriconazole by using new intermediates

Inventors: Hyuk Chul Kwon (Gyeonggi-Do, KR); Man Dong Rho (Seoul, KR); Kyung Hoi Cha (Gyeonggi-Do, KR)
Assignee: Dongkook Pharmaceutical Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,575,344
App. No.
13/577,055
Granted
Nov 5, 2013
Kind
B2
Abstract

Provided is a process for preparing Voriconazole represented by Chemical Formula 1. More particularly, the process for preparing Voriconazole of Chemical Formula 1 includes: carrying out the Reformatsky-type coupling reaction between a ketone derivative of Chemical Formula 4 and a pyrimidine derivative of Chemical Formula 5 to obtain a compound of Chemical Formula 3; reacting the substituents halo and oxysulfonyl with a hydrogen donor to obtain racemic Voriconazole of Chemical Formula 2; and carrying out optical isolation of the racemic Voriconazole by adding an adequate optically active acid thereto to obtain Voriconazole having high optical purity with high cost-efficiency and high yield.

Claims (14)

1. A process for preparing Voriconazole of the following Chemical Formula 1, comprising the steps of:

1) carrying out the Reformatsky-type coupling reaction between a compound of the following Chemical Formula 4 and a compound of the following Chemical Formula 5 to obtain a compound of the following Chemical Formula 3;

2) removing the substituents X 1 , X 2 and OSO 2 R from the compound of Chemical Formula 3 to obtain racemic Voriconazole of the following Chemical Formula 2, with the proviso that X 1 and X 2 are not removed when they both represent H; and

3) separating the isomers of the compound of Chemical Formula 2 with an optically active acid:

wherein X 1 and X 2 independently represent H or halo; and

R is C 1 -C 4 alkyl or substituted or non-substituted phenyl, wherein the substituted phenyl may be substituted with at least one substituent selected from the group consisting of C 1 -C 4 alkyl, alkoxy, halo, nitro and oxo.

2. The process according to claim 1 , wherein the Reformatsky-type coupling reaction in step 1) is carried out at a temperature ranging from −15° C. to 0° C.

3. The process according to claim 1 , wherein step 2) is carried out by using Pd/C, Raney nickel or zinc as a catalyst.

4. The process according to claim 3 , wherein Pd/C is used in an amount of 2-30 wt % based on the amount of the compound of Chemical Formula 3.

5. The process according to claim 1 , wherein step 2) is carried out by using hydrogen or ammonium formate as a hydrogen donor.

6. The process according to claim 1 , wherein step 2) is carried out by using toluene, benzene, xylene or a mixture containing two or more of them as a reaction solvent.

7. The process according to claim 1 , wherein the compound of Chemical Formula 4 is obtained by reacting a compound represented by the following Chemical Formula 6 with a compound represented by the following Chemical Formula 7 under basic conditions:

wherein X 1 and X 2 independently represent H or halo.

8. The process according to any one of claims 1 to 7 , wherein X 1 and X 2 independently represent bromine.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2012
From: KWON, HYUK CHUL; RHO, MAN DONG; CHA, KYUNG HOI
To: DONGKOOK PHARMACEUTICAL CO., LTD.
Reel/Frame 028718/0525 →
Priority Claims (1)
KR 10-2010-0010467 · Feb 4, 2010 · national
Continuity (1)
Related Publication 20130005973A1 · Jan 3, 2013